Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits
Elena Maneschi Molecular and Cellular Endocrinology Volume 424, 15 March 2016, Pages 50–70
• Tadalafil reduced visceral fat accumulation (VAT) in an animal model of MetS.
• Tadalafil dosing induced the expression of UCP1 (brown-fat marker) in visceral fat.
• Tadalafil improved insulin sensitivity in preadipocytes (PAD) isolated from VAT.
• Tadalafil promoted PAD differentiation towards a metabolically healthy phenotype.
Development of metabolically healthy adipocytes within dysfunctional adipose tissue may represent an attractive way to counteract metabolic syndrome (MetS). In an experimental animal model of high fat diet (HFD)-induced MetS, in vivo, long- and short-term tadalafil treatments were able to reduce visceral adipose tissue (VAT) accumulation and hypertriglyceridemia, and to induce the expression in VAT of the brown fat-specific marker, uncoupling protein 1 (UCP1). VAT preadipocytes (PAD), isolated from the tadalafil-treated HFD rabbits, showed: i) a multilocular morphology; ii) an increased expression of brown fat-specific genes (such as UCP1 and CIDEA); iii) improved mitochondrial structure and dynamic and reduced superoxide production; iv) improved insulin sensitivity. Similar effects were obtained after in vitro tadalafil treatment in HFD rPAD. In conclusion, tadalafil counteracted HFD-associated VAT alterations, by restoring insulin-sensitivity and prompting preadipocytes differentiation towards a metabolically healthy phenotype.
Voir aussi :
- L'ostéocalcine est une hormone anabolique pour les muscles
- Trop de leucine: néfaste pour le cœur des sportifs?
- De la théobromine pour remplacer le fluor des dentifrices
- Les poids lourds plus efficaces que les poids légers pour l'hypertrophie
- Stimuler ou inhiber mTOR pour la santé cérébrale?